...
首页> 外文期刊>Zeitschrift fur Anorganische und Allgemeine Chemie >Synthesis of a Ruthenium(II) Compound based on 5-(2-Pyrimidyl)-1H-tetrazole for Photodynamic Therapy
【24h】

Synthesis of a Ruthenium(II) Compound based on 5-(2-Pyrimidyl)-1H-tetrazole for Photodynamic Therapy

机译:基于5-(2-嘧啶)-1H-四唑用于光动力治疗的钌(II)化合物的合成

获取原文
获取原文并翻译 | 示例
           

摘要

Ru-II compounds have been universally investigated due to their unique physical and chemical properties. In this paper, a new Ru-II compound based on 2,2-bipy and Hpmtz [2,2-bipy = 2,2-bipyridine, Hpmtz = 5-(2-pyrimidyl)-1H-tetrazole], namely [Ru(2,2-bipy)(2)(pmtz)][PF6].0.5H(2)O was prepared and characterized by elemental analysis, IR and single-crystal X-ray diffraction. [Ru(2,2-bipy)(2)(pmtz)][PF6].0.5H(2)O shows a mononuclear structure and forms a three-dimensional network by non-classic hydrogen bonds. The ability of generation of ROS (reactive oxygen species) makes it has a low phototoxicity IC50 (half-maximal inhibitory concentration) after Xenon lamp irradiation on Hela cells in vitro. The results demonstrate that [Ru(2,2-bipy)(2)(pmtz)][PF6].0.5H(2)O with high light toxicity and low dark toxicity may be a potential candidate for photodynamic therapy.
机译:由于其独特的物理和化学性质,Ru-II化合物已被普遍研究。 本文中,基于2,2-Bipy和HPMTz的新Ru-II化合物[2,2-Bipy = 2,2-吡啶,HPMTZ = 5-(2-嘧啶基)-1H-四唑],即[ru (2,2-Bipy)(2)(2)(PMTZ)] [PF6] .0.5H(2)o通过元素分析,IR和单晶X射线衍射来制备和表征。 [Ru(2,2-Bipy)(2)(2)(PMTZ)] [PF6] .0.5H(2)O显示单核结构,并通过非经典氢键形成三维网络。 在体外,在氙灯照射后,在氙灯照射后,产生ROS(反应性氧物质)的能力使其具有低光毒性IC50(半最大抑制浓度)。 结果表明,具有高光毒性和低暗毒性的[Ru(2,2-Bipy)(2)(PMTZ)],0.0.5H(2)o可以是光动力治疗的潜在候选者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号